Trial Details

COMPLETED
Basic Information
Clinical ID c4292
Identifier NCT00737932
Trial Title Laquinimod Phase IIa Study in Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: Laquinimod|OTHER: placebo
Participant Information
Sponsor Teva Branded Pharmaceutical Products R&D, Inc.
City Bonheiden
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-05
Primary Completion Date 2011-11
Completion Date 2011-12